Home > Company

CORE VALUE

Realize prompt and accurate molecular diagnostics and support early-stage

diagnosis and timely personalized medicine. 

We are developing nucleic acid preparation and MDx and CDx technology targeting various infectious diseases and genetic disorders including COVID-19, mycobacterium tuberculosis,

fungal diseases, Orientia tsutsugamushi and liquid biopsy from cancers. 

EXPERTISE

Focus on developing products that exhibit optimal

performance in the MDx market.

HORIZONTAL

Pursue efficient cooperation in a horizontal company

culture and releasing a wide range of MDx products. 

ORIGINALITY

Encourage creative thinking and put our efforts

on developing innovative products.

We are focused on developing innovative technology that could continuously contribute to medical diagnosis even in the circumstances of rapidly changing IVD market.

Our development goal is to realize prompt and accurate MDx even when there are low quantity of pathogens from various diseases.

INFUSIONTECH, Inc.ㅣ CEO : Nam Heon, Kim

 Tel: +82-31-687-3459 

FAX : +82-31-624-1518 

 E-Mail: infusion@infusiontech.co.kr

#1202, 38, Heungan-daero 427 beon-gil, Dongan-gu, Anyang-si, Gyeonggi-do, Korea 

INFUSIONTECH, Inc.ㅣ CEO : Nam Heon, Kim

 Tel: +82-31-687-3459 ㅣFAX : +82-31-624-1518 ㅣ E-Mail: infusion@infusiontech.co.kr

#1202, 38, Heungan-daero 427 beon-gil, Dongan-gu, Anyang-si, Gyeonggi-do, Korea 

COPYRIGHT INFUSIONTECH © 20‌20. ALL RIGHTS RESERVED.